Back
Caliway Seeks FDA Nod for Drug Targeting GLP-1 Weight Regain
Back
Stock News
Themes
Caliway Seeks FDA Nod for Drug Targeting GLP-1 Weight Regain
Donald Trump
Caliway Seeks FDA Nod for Drug Targeting GLP-1 Weight Regain
Edgen Stock
·
Dec 25 2025, 13:59
Share to
Share to
Copy link
source:
[1] Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies
Recommend
Citi Raises PBF Energy Target to $36 After 14.8% Stock Gain
Jan 17 2026, 06:20
Dow Appoints New CTO to Unify Tech and Sustainability Goals
Jan 17 2026, 06:10
Mediacom Founder Rocco Commisso Dies, Sparking Leadership Questions
Jan 17 2026, 06:05
Edgen Stock·Dec 25 2025, 13:59Edgen Stock·Dec 25 2025, 13:59
Edgen Stock·Dec 25 2025, 13:59